Correlation Between Pharmala Biotech and Avenue Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pharmala Biotech and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmala Biotech and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmala Biotech Holdings and Avenue Therapeutics, you can compare the effects of market volatilities on Pharmala Biotech and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmala Biotech with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmala Biotech and Avenue Therapeutics.

Diversification Opportunities for Pharmala Biotech and Avenue Therapeutics

-0.12

Correlation Coefficient

Pharmala Biotech  Avenue Therapeutics

Good diversification

The 3 months correlation between Pharmala and Avenue is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Pharmala Biotech Holdings and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Pharmala Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmala Biotech Holdings are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Pharmala Biotech i.e., Pharmala Biotech and Avenue Therapeutics go up and down completely randomly.

Pair Corralation between Pharmala Biotech and Avenue Therapeutics

If you would invest  25.00  in Pharmala Biotech Holdings on September 17, 2024 and sell it today you would earn a total of  0.00  from holding Pharmala Biotech Holdings or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	4.76%
Values	Daily Returns

Pharmala Biotech Holdings  vs.  Avenue Therapeutics

Pharmala Biotech Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Avenue Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avenue Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Pharmala Biotech and Avenue Therapeutics

The main advantage of trading using opposite Pharmala Biotech and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmala Biotech position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.

The idea behind Pharmala Biotech Holdings and Avenue Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.